[AIDS Medicines in Development]

Anti-infectives DRUG NAME COMPANY INDICATION U.S. DEVELOPMENT STATUS Clindamycint with Upjohn PCP treatment Phase I/II Primaquine (Kalamazoo, MI) Dapsone with Jacobus Pharmaceuticals PCP prophylaxis Phase II/III NebuPent~ (Princeton, NJ) (Aerosol Pentamidine Isethionate) Dapsone with Jacobus Pharmaceuticals PCP prophylaxis Phase III Retrovir~ (AZT) (Princeton, NJ) Daraprim~ Burroughs Wellcome toxoplasmosis prophylaxis Phase III Pyrimethamine (Rsch. Triangle Park, NC) Diclazuril Janssen Pharmaceutica cryptosporidiosis Phase I (Piscataway, NJ) Mycostatin~t Bristol-Myers Squibb prevention of oral candidiasis Phase III Pastille (New York, NY) Nystatin Pastille NebuPent~ Fujisawa Pharmaceutical PCP treatment Phase III Aerosol Pentamidine (Deerfield, IL) (Orphan Drug) Isethionate Nizoral~ Janssen Pharmaceutica candida esophagitis Phase III Ketoconazole (Piscataway, NJ) (suspension) Piritrexim Burroughs Wellcome PCP treatment Phase I/II (Rsch. Triangle Park, NC) PneumopentTM Fisons Corporation PCP prophylaxis application submitted Aerosol Pentamidine (Bedford, MA) Isethionate Rifabutin Adria Labs MAI prophylaxis Phase III (Columbus, OH) SCH39304/42427 Schering-Plough opportunistic fungal infections, Phase II/III (Madison, NJ) including aspergillosis, candidiasis, cryptococcal meningitis; empirical treatment in neutropenic sepsis Septra~ Burroughs Wellcome PCP prophylaxis Phase III Trimethoprim and (Rsch. Triangle Park, NC) Sulfamethoxazole Spiramycin Rhone-Poulenc cryptosporidial diarrhea Phase II/III Pharmaceuticals (Princeton, NJ) Sporanox~ Janssen Pharmaceutica maintenance therapy for Phase III Itraconazole- (Piscataway, NJ) cryptococcal meningitis, R51211 histoplasmosis TLC-G-65 Liposome Co. MAI infection Phase I Gentamicin (Princeton, NJ) (Orphan Drug) Liposome (injection) Other DRUG NAME COMPANY INDICATION U.S. DEVELOPMENT STATUS Megace~ t Bristol-Myers Squibb treatment of anorexia and cachexia Phase II/III Megestrol Acetate (New York, NY) associated with AIDS Mesalamine Norwich Eaton inflammatory bowel syndrome Phase I/II (Norwich, NY) associated with HIV infection, ARC, AIDS Sandostatin~ t Sandoz HIV-related diarrhea Phase II/III Somatostatin (East Hanover, NJ)

/ 8

Actions

file_download Download Options Download this page PDF - Pages #1-8 Image - Page #5 Plain Text - Page #5

About this Item

Title
[AIDS Medicines in Development]
Author
Pharmaceutical Research and Manufacturers of America
Canvas
Page #5
Publication
Pharmaceutical Manufacturers Association
1990
Subject terms
reports
Item type:
reports

Technical Details

Link to this Item
https://name.umdl.umich.edu/5571095.0504.022
Link to this scan
https://quod.lib.umich.edu/c/cohenaids/5571095.0504.022/5

Rights and Permissions

The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.

Manifest
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0504.022

Cite this Item

Full citation
"[AIDS Medicines in Development]." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0504.022. University of Michigan Library Digital Collections. Accessed June 13, 2025.
Do you have questions about this content? Need to report a problem? Please contact us.